Loading...
Keywords
Last Name
Institution

Search Results (38)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.Academic Article Why?
Gamis, AlanPerson Why?
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.Academic Article Why?
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study.Academic Article Why?
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.Academic Article Why?
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML.Academic Article Why?
CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients.Academic Article Why?
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.Academic Article Why?
Earlier initiation of antibiotic therapy: Does prophylaxis offer greater benefit in AML?Academic Article Why?
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.Academic Article Why?
AmlodipineConcept Why?
Amlodipine Besylate, Olmesartan Medoxomil Drug CombinationConcept Why?
Amlodipine, Valsartan Drug CombinationConcept Why?
A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials.Academic Article Why?
Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.Academic Article Why?
Per Page    Page  of 3last Nextnext
Prev
Search Criteria
  • AML
Filter by Type